Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Annexon Inc.
Sponsor

Annexon Inc.

United States 1400 Sierra Point Parkway, 94005-1808, United States

About the sponsor

Annexon Inc. is active in dry age-related macular degeneration with geographic atrophy, focusing on visual function, visual acuity, and the preservation of retinal integrity.

  • Dry age-related macular degeneration
  • Geographic atrophy
  • Visual acuity
  • Intravitreal therapy

The sponsor’s ophthalmic research reflects interest in retina-targeted treatment for progressive degenerative eye disease.

About Specializations

Annexon Inc. runs clinical trials in conditions such as Guillain-Barre syndrome, Dry age-related macular degeneration, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Guillain-Barre syndrome

Recruiting

A Study of ANX005 for Patients Recently Diagnosed with Guillain-Barré Syndrome to Evaluate How the Drug Works in the Body and Its Safety

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Humanised IgG4 monoclonal antibody against C1Q
  • Sponsor:Annexon Inc.

Dry age-related macular degeneration

Not recruiting

Study on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:ANX007
  • Sponsor:Annexon Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.